Studies of the cardiovascular effects of nociceptin and related peptides

Peptides

Volumn 21, Issue 7, 2000, Pages 985-993

  Salis, Maria Bonaria ^a   Emanueli, Costanza ^a   Milia, Anna Franca ^a   Guerrini, Remo ^c   Madeddu, Paolo ^a,b  

^a National Laboratory   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DYNORPHIN A; NALOXONE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG SYNTHESIS; HEART FUNCTION; HEART RATE; HOMEOSTASIS; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ION CHANNELS; LIGANDS; MICE; MYOCARDIUM; OPIOID PEPTIDES; PEPTIDES; TIME FACTORS; VASODILATOR AGENTS;

EID: 0033811692     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00238-2     Document Type: Article

References (44)

1. Andoh T., Itoh M., Kuraishi Y. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. Neuroreport. 8:1997;2793-2796.
2. ca channel activation. Brain Res. 835:1999;315-323.
3. Arndt M.L., Wu D., Soong Y., Szeto H.H. Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep. Peptides. 20:1999;465-470.
4. 2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br J Pharmacol. 126:1999;555-558.
5. Bigoni R., Giuliani S., Calo' G., et al. Characterization of nociceptin receptors in the periphery in vitro and in vivo studies . Naunyn-Schmiedebergs Arch Pharmacol. 359:1999;160-167.
6. Brooks H., Elton C.D., Smart D., Rowbotham D.J., McKnight A.T., Lambert D.G. Identification of nociceptin in human cerebrospinal fluid comparison of levels in pain and non-pain states . Pain. 78:1998;71-73.
7. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not μ, δ or κ opioid receptor type. FEBS Lett. 347:1994;284-288.
8. 2 is an agonist of the nociceptin (ORL-1) receptor. Eur J Pharmacol. 349:1998;R5-R6.
9. 2, a novel selective nociceptin receptor antagonist. In International Narcotics Research Conference, 30th Meeting, Saratoga Springs, NY, USA, S1-5: 10-15 July, 1999.
10. Calo' G., Rizzi A., Bigoni R., et al. The mouse vas deferens a pharmacological preparation sensitive to nociceptin . Eur J Pharmacol. 311:1996;R3-R5.
11. Calo' G., Rizzi A., Bodin M., et al. Pharmacological characterization of nociceptin receptor an in vitro study . Can J Physiol Pharmacol. 75:1997;713-718.
12. Calo' G, Rizzi A, Bogoni G, et al. Nociceptin and its receptor: a structure activity study. In 7th Annual Meeting-European Neuropeptide Club; Marburg, Germany, page C1: May 1997:21-4.
13. Champion H.C., Bivalacqua T.J., Friedman D.E., Zadina J.E., Kastin A.J., Kadowitz P.J. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat. Peptides. 19:1998;1595-1602.
14. Champion H.C., Czapla M.A., Kadowitz P.J. Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat. Peptides. 18:1997;729-732.
15. Champion H.C., Kadowitz P.J. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat. Life Sci. 60:1997;241-245.
16. Champion H.C., Pierce R.L., Kadowitz P.J. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat. Regul Pept. 78:1998;69-74.
17. Champion H.C., Zadina J.E., Kastin A.J., Hackler L., Ge L.J., Kadowitz P.J. Endomorphin 1 and 2 endogenous ligands for the μ-opioid receptor, decrease cardiac output and total peripheral resistance in the rat . Peptides. 18:1997;1393-1397.
18. Champion H.C., Zadina J.E., Kastin A.J., Hackler L., Ge L.J., Kadowitz P.J. The endogenous μ-opioid receptor agonists endomorphins 1 and 2 have a novel hypotensive activity in the rabbit. Biochem Biophys Res Commun. 235:1997;567-570.
19. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kizak C.A., Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:1994;279-283.
20. Chu X., Xu N., Li P., Mao L., Wang J.Q. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla. Brain Res. 829:1999;134-142.
21. Clapp J.F. III, Kett A., Olariu N., et al. Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep. Am J Obstet Gynecol. 178:1998;397-401.
22. Czapla M.A., Champion H.C., Kadowitz P.J. Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat. Peptides. 18:1997;793-795.
23. Czapla M.A., Champion H.C., Kadowitz P.J. Decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not inhibited by naloxone in the rat. Peptides. 18:1997;1197-1200.
24. 3H]nociceptin binding site in membrane preparations of rat hearts correlations with the non-opioid dynorphin binding site . J Mol Cell Cardiol. 30:1998;2751-2760.
25. Fukuda K., Kato S., Mori K., et al. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
26. Gintzler A.R., Adapa I.D., Toll L., Medina V.M., Wang L. Modulation of enkephalin release by nociceptin (orphanin FQ). Eur J Pharmacol. 325:1997;29-34.
27. Giuliani S., Tramontana M., Lecci A., Maggi C.A. Effect of nociceptin on heart rate and blood pressure in anesthetized rats. Eur J Pharmacol. 333:1997;177-179.
28. Guerrini R., Calo' G., Rizzi A., et al. A new selective antagonist of the nociceptin receptor. Br J Pharmacol. 123:1998;163-165.
29. Gumusel B., Hao Q., Hyman A., Chang J.K., Kapusta D.R., Lippton H.L. Nociceptin an endogenous agonist for central opioid like (ORL-1) receptors possesses systemic vasorelaxant properties . Life Sci. 60:1997;141-145.
30. Habler H.J., Timmermann L., Stegman J.-U., Jang W. Effects of nociceptin and nocistatin on antidromic vasodilatation in hairless skin of the rat hindlimb in vivo. Br J Pharmacol. 127:1999;1719-1727.
31. 2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. J Pharmacol Exp Ther. 289:1999;173-180.
32. Kapusta D.R., Sezen S.F., Chang J.K., Lippton H., Kenigs V.A. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci. 60:1997;PL15-PL21.
33. Lin B., Lippton H. Nociceptin receptor activation produces nitric oxide-mediated systemic hypotension. Pharmacol Lett. 66:2000;L99-L104.
34. Madeddu P., Salis M.B., Milia A.F., Emanueli C., Guerrini R., Regoli D., Calo' G. Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension. 33:1999;914-919.
35. Meunier J.C. Nociceptin/Orphanin FQ, and the opioid receptor-like ORL1 receptor. Eur J Pharmacol. 340:1997;1-15.
36. Meunier J.C., Mollereau C., Toll L., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
37. Montiel J.L., Cornille F., Roques B.P., Noble F. Nociceptin/Orphanin FQ metabolism role of aminopeptidase and endopeptidase 24 . 15. J Neurochem. 68:1997;354-361.
38. Narita M., Mizoguchi H., Oji D.E., et al. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPγS binding and immunohistochemistry. Br J Pharmacol. 128:1999;1300-1306.
39. Noble F., Roques B.P. Association of aminopeptidase 24. 15 inhibitors potentiates behavioral effects mediated by nociceptin/orphanin FQ in mice. FEBS Lett. 401:1997;227-229.
40. Nothacker H.P., Reinscheid R.K., Mansour A., et al. Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA. 93:1996;8677-8682.
41. Reinscheid R.K., Nothacker H.P., Bourson A., et al. Orphanin FQ a neuropeptide that activates an opioidlike G protein- coupled receptor . Science. 270:1995;792-794.
42. Toll L, Burnside J, Berzetei-Gurske I. Agonist activity of ORL1 antagonists is dependent upon receptor number. In International Narcotics Research Conference, Garmisch Partenkirchen; page A 89; July 20-25,1998.
43. Ventura C., Pintus G. Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B. J Biol Chem. 272:1997;6699-6705.
44. Zimlichman R., Gefel D., Eliahou H., et al. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation. 93:1996;1020-1025.